Related Experiment Video
Updated: Sep 27, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Revascularization strategies for patients with established chronic coronary syndrome
Casper F Coerkamp1, Marieke Hoogewerf2,3, Bart P van Putte2
1Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Insights
Coronary artery disease treatments are advancing rapidly. This review highlights the importance of personalized revascularization strategies, combining medical therapy with interventions like percutaneous coronary intervention or coronary artery bypass grafting, tailored to individual patient needs.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) is a leading cause of global mortality.
- While medical therapy is effective for many, revascularization remains crucial for numerous patients.
- Advances in percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are rapidly improving outcomes.
Purpose of the Study:
- To provide an updated overview of myocardial revascularization strategies for chronic coronary syndrome.
- To emphasize the importance of patient-tailored decision-making in revascularization.
- To interpret recent trial outcomes in the context of evolving techniques and trial designs.
Main Methods:
- Review of recent technical innovations in coronary stents and surgical strategies.
- Analysis of optimal coronary target and graft selection criteria.
- Evaluation of evidence-based patient-tailored decision-making by the Heart Team.
Main Results:
- Significant progress in PCI and CABG through technical innovation.
- Improved outcomes linked to refined techniques, stent technology, and minimally invasive approaches.
- Growing evidence supports tailoring revascularization strategies to individual patient profiles.
Conclusions:
- Revascularization strategies for CAD require careful interpretation of research outcomes.
- Patient-tailored decision-making is fundamental for optimal results.
- An updated understanding of revascularization is essential given recent guideline publications and trial data.
Abstract:
Coronary artery disease is the most common type of cardiovascular disease, leading to high mortality rates worldwide. Although the vast majority can be treated effectively and safely by medical therapy, revascularization strategies remain essential for numerous patients. Outcomes of both percutaneous coronary intervention and coronary artery bypass grafting improve in a rapid pace, resulting from technical innovation and ongoing research. Progress has been achieved by technical improvements in coronary stents, optimal coronary target and graft selection, and the availability of minimally invasive surgical strategies. Besides technical progress, evidence-based patient-tailored decision-making by the Heart Team is the basic precondition for optimal outcome. The combination of fast innovation and long-term clinical evaluations creates a dynamic field. Research outcomes should be carefully interpreted according to the techniques used and the trial's design. Therefore, more and more trial outcomes suggest that revascularization strategies should be tailored towards the specific patient. Although the European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines on myocardial revascularization date from 2018 and a large variety of trial outcomes on revascularization strategies in chronic coronary syndrome have been published since, we aim to provide an updated overview within this review.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome V: Nursing Management
Atherosclerosis III: Management

